Annual Drug Patent Expirations for LODOCO Lodoco is a drug marketed by Agepha Pharma Fz and is included in one NDA. It is available from one supplier. There are eight…
Source
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
This chart shows which pharmaceutical companies received the most new drug approvals last year. The drug companies with the most new drugs last year are Baxter Hlthcare Corp Pfizer Exela…
Source
Pharmaceutical companies with the most drug approvals last year Read Post »
EXSERVAN (riluzole) Aquestive Patent: 8,603,514 Expiration: Apr 3, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source
Drug Patent Expirations for the Week of March 31, 2024 Read Post »
Annual Drug Patent Expirations for MINOCIN Minocin is a drug marketed by Bausch, Triax Pharms, Lederle, and Rempex and, and is included in five NDAs. It is available from two…
Source
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier. There are seven patents protecting…
Source
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
This chart shows the pharmaceutical companies with the most patents in Argentina. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the most drug patents in Argentina? Read Post »
Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are four patents protecting…
Source
Annual Drug Patent Expirations for ISENTRESS+HD Isentress Hd is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from nine suppliers. There are…
Source
New patent expiration for Msd Sub drug ISENTRESS HD Read Post »
Get new actionable insights and updates from BiotechBlog
